Congress Materials – American Thoracic Society (ATS 2025)
2025 American Thoracic Society | May 17-21 | San Francisco, CA
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
A team-based patient engagement approach to selexipag initiation and maintenance in Pulmonary Arterial Hypertension (TEAM PAH): Interim analysis of a real-world retrospective study
Amanda Schnell Heringer, Samuel B Brusca, Sumeet Panjabi, Sarah Walden, Gurinderpal Doad, Michelle Cho, Ambika Satija, Gayatri Marathe, Henrietta Blinder, Marjolaine Gauthier-Loiselle, Teresa De Marco
Long-term treatment with single-tablet combination of macitentan and tadalafil in pulmonary arterial hypertension (PAH): final results from the A DUE open-label extension
H. James Ford, Kelly M. Chin, Fenling Fan, Michael Friberg, Ekkehard Grünig, Jakob A. Hauser, Matthieu Pannaux, Hany Rofael, Pavel Jansa
Qualitative Interviews of Patients with Meth-APAH: Understanding the Unmet Medical Need from the Patient Lens
Lana Melendres-Groves, Vinicio De Jesus Perez, Anjali Vaidya, Hyein G. Lee, Marinella Sandros, David Lopez, Ankita Adhia, Natalie Gearhart, Michelle Cho, John F. Kingrey
Physicians Managing Patients with Methamphetamine-associated Pulmonary Arterial Hypertension: Understanding the Unmet Medical Needs from a Provider Lens
John F. Kingrey, Nick H Kim, Sonja Bartolome, Jeffrey Robinson, Hyein G. Lee, Marinella Sandros, David Lopez, Ankita Adhia, Natalie Gearhart, Michelle Cho, Lana Melendres-Groves
Real-world retrospective cohort study of oral selexipag in methamphetamine-associated Pulmonary Arterial Hypertension: An interim analysis from TEAM PAH
Samuel B Brusca, Amanda Schnell Heringer, Sumeet Panjabi, Sarah Walden, Gurinderpal Doad, Michelle Cho, Ambika Satija, Gayatri Marathe, Henrietta Blinder, Marjolaine Gauthier-Loiselle, Teresa De Marco
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.